Tandem Diabetes Care

Tandem Diabetes Care is a medical device company that develops, manufactures and sells automated insulin delivery systems for people with insulin-dependent diabetes. Founded in 2006 and headquartered in San Diego, California, it is publicly traded on Nasdaq. Its work spans predictive algorithms, embedded software and device design, medical device manufacturing and the integration of continuous glucose monitoring data.

The company's product line includes the Tandem Mobi and t:slim X2 insulin pumps, along with Control-IQ+ technology, a proprietary predictive algorithm with AutoBolus that automates insulin delivery to improve glucose control and simplify diabetes management. The company describes Control-IQ+ as the only technology of its kind on the market. Beyond its devices, Tandem provides comprehensive support programmes and services for both healthcare providers and patients.

Engineering and design work at Tandem covers automated insulin delivery, predictive algorithms, embedded software, device design and continuous glucose monitoring integration, applying a human-centred approach to product development. The company states its aim as creating new possibilities for people living with insulin-dependent diabetes, with a mission that extends past its products to patient and provider support.